Abstract-Biosensors are commonly produced using a siliconon-insulator (SOI) CMOS process and advanced lithography to define nanowires. In this paper, a simpler and cheaper junctionless three-mask process is investigated, which uses thin-film technology to avoid the use of SOI wafers, in situ doping to avoid the need for ion implantation and direct contact to a low-doped polysilicon film to eliminate the requirement for heavily doped source/drain contacts. Furthermore, TiN is used to contact the biosensor source/drain because it is a hard resilient material that allows the biosensor chip to be directly connected to a printed circuit board without wire bonding. pH sensing experiments, combined with device modeling, are used to investigate the effects of contact and series resistance on the biosensor performance, as this is a key issue when contacting directly to low-doped silicon. It is shown that in situ phosphorus doping concentrations in the range 4 × 10 17 -3 × 10 19 cm −3 can be achieved using 0.1% PH 3 flows between 4 and 20 sccm. Furthermore, TiN makes an ohmic contact to the polysilicon even at the bottom end of this doping range. Operation as a biosensor is demonstrated by the detection of C-reactive protein, an inflammatory biomarker for respiratory disease.
I. INTRODUCTION
O VER the past decade, silicon nanowires have been widely researched for application as biochemical sensors [1] - [12] . Silicon nanowires are of interest for a number of reasons, for example, a high surface-to-volume ratio gives high sensitivity and electrical sensing gives real-time labelfree detection without the use of expensive optical components. Initial research used bottom-up self-assembly [1] , [2] for nanowire fabrication, which involves the use of a metal catalyst to grow the nanowires. A nanowire alignment tech- nology is also needed, such as electric field or fluid-flowassisted nanowire positioning to locate the nanowires between lithographically defined source and drain electrodes [3] . The bottom-up approach has the advantage of simplicity, but precise control of nanowire size and position is very difficult. Top-down approaches overcome these shortcomings, and several groups have used advanced lithography techniques to fabricate single-crystal silicon nanowires on silicon-oninsulator (SOI) wafers [4] - [9] . This has the advantage of CMOS compatibility for the development of sensor systems, but a serious disadvantage is the high cost associated with advanced lithography techniques and expensive SOI wafers. Low-cost manufacture is critically important for nanowire biosensor applications because for widespread uptake of biosensors in Point of Care settings, the biosensor needs to be disposable and hence very cheap. Several groups [10] - [12] have researched top-down approaches that do not need advanced lithography using coarser lithography and specialist wet etches to reduce the nanowire diameter. However, these approaches still use expensive SOI wafers and have the disadvantage that wet etches are generally not favored for manufacturing. An alternative to CMOS-based nanowire technologies is to use thin-film transistor (TFT) technology on non-SOI substrates, as is widely used for the manufacture of displays. This approach offers the prospect of very low cost, because displays are mass manufactured as large panels (2.88 m × 3.13 m for Sharp 10th generation), which are then cut to smaller sizes for application in TV, computer, and mobile phone screens. This gives a very low cost per unit substrate area. Several groups [13] - [16] have reported topdown approaches for the fabrication of polysilicon nanowires using variants of TFT technology. In our previous work [15] , we reported a technology for producing rectangular polysilicon nanowire biosensors and demonstrated the detection of two inflammatory biomarkers, the proteins interleukin-8 and tumor necrosis factor-alpha, over a wide range of concentrations and with excellent sensitivity.
In this paper, we report a very simple junctionless polysilicon TFT biosensor for application in Point of Care diagnostics that can be fabricated with just three masks for polysilicon definition, metallization, and sensing window definition. This small mask count has been achieved using a thin in situ low-doped polysilicon layer without any highly doped contact regions. pH sensing is used to assess biosensor performance, and device modeling is performed to assess the effect of contact resistance. The operation of the TFTs as biosensors 0018-9383 © 2014 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission.
See http://www.ieee.org/publications_standards/publications/rights/index.html for more information. is demonstrated by the sensing of the inflammatory biomarker C-reactive protein (CRP) in buffer solution. The TFT biosensor technology is compatible with TFT display technology and hence highly manufacturable.
II. EXPERIMENTAL PROCEDURE
The TFT biosensor fabrication technology is shown schematically in Fig. 1 . N-type <100> silicon wafers were used as substrate. A 100 nm silicon dioxide layer was then grown by wet thermal oxidation and a 300 nm silicon nitride layer deposited by low-pressure chemical vapor deposition. A 45 nm amorphous silicon layer was then deposited at 200°C using an Oxford Instruments Plasma Technology PlasmaPro 100 plasma enhanced chemical vapour deposition (PECVD) system. In situ doping was achieved using 0.1% PH 3 gas, and the flow rate was varied between 4 and 40 sccm, while the SiH 4 and H 2 flows were both kept constant at 100 sccm, and Ar flow was varied between 296 and 260 sccm to fix a total gas flow of 500 sccm. The process pressure was set at 800 mtorr and the RF power at 10 W. The first lithography step [ Fig. 1(a) ] was used to define the TFT biosensor geometry, and an 8.5 nm gate oxide was then grown at 900°C in O 2 to create a gate insulator for the liquid gate. This gate oxidation also crystallized the amorphous silicon into polycrystalline silicon and activated the phosphorus dopant.
The second lithography step was used to define the metallization patterns prior to metal deposition and lift-off. TiN was chosen for the metallization because it is a hard resilient material [17] that can easily be connected to a printed circuit board using a SAMTEC SEI series connector [ Fig. 2 process do not include heavily doped source/drain areas or p-n junctions, and are therefore junctionless TFTs. To investigate the effect of source/drain pads, some devices were produced with heavily doped n+ source/drain regions. These n+ contacts were produced using a separate in situ doped polysilicon layer deposited at 200°C using 10% PH 3 , SiH 4 , H 2 , and Ar gases at a flow rate of 2, 50, 100, and 348 sccm. Fig. 2(b) shows an optical micrograph of the completed TFT biosensor.
The pH measurements were made using a liquid gate, with an Ag/AgCl electrode biased at 10 mV and a source/drain bias of 100 mV, as shown in Fig. 2 (c). The low liquid gate bias was chosen to avoid electrolysis in the buffer solution and to minimize any leakage current, while keeping the device in the subthreshold region. The substrate was kept at ground for all electrical measurements. To demonstrate the operation of the low-doped TFT as a biosensor, low-doped TFT biosensors were functionalized with anti-CRP antibody to create a biosensor for CRP sensing. The surface of the TFT was then exposed to increasing concentrations of CRP molecules suspended in 0.1 mM phosphate buffer (pH7).
The electrical results obtained in air on the TFT biosensor were interpreted using Silvaco Atlas device simulations [18] . To simulate the polysilicon layer, a uniform doping profile and a 1.1 μm grain size was assumed, with 10 nm grain boundaries (GBs; in a real layer, there can be large variations in grain size and orientation). The grains were assumed to be defect-free, and all defects were incorporated in the GBs using the default defect model parameters. The simulations used the Lombardi mobility model and the Shockley-Read-Hall recombination model.
III. RESULTS AND DISCUSSION
The sheet resistance of the amorphous silicon was measured by four-point probe and was found to be very high after deposition at 200°C, indicating that dopant activation is very low. However, after gate oxidation at 900°C, the sheet resistance decreases dramatically. Fig. 3 shows the sheet resistance after a 900°C oxidation as a function of PH 3 flow. A sheet resistance of 140 k /sq is obtained for a PH 3 flow of 4 sccm, which then drops to 1.8 k /sq for a PH 3 flow of 40 sccm. The Hall effect mobility was measured on a polysilicon layer deposited using a PH 3 flow of 20 sccm, and a value of 29 cm 2 /Vs was obtained. Using this value of mobility, an average doping concentration of around 4×10 17 cm −3 is estimated for a PH 3 flow of 4 sccm and around 3 × 10 19 cm −3 for a PH 3 flow of 20 sccm. To gain an indication of the sensitivity of the TFT biosensor at different doping concentrations, the effect of pH on drain/source current was explored with low-doped (PH 3 flow of 4 sccm) and high-doped (PH 3 flow of 20 sccm) devices. The results are shown in Fig. 5 , where the normalized conductance change is plotted as a function of pH for two high-doped and two low-doped TFT biosensors. The error bars represent the standard deviation of five consecutive measurements at the same pH. A conductance change of just below 6% is obtained at a pH of 3 for the low-doped biosensor and around 4% for the high-doped biosensor. This result is qualitatively as expected, since modeling shows that biosensor sensitivity is inversely proportional to the doping concentration [19] .
When the polysilicon doping is low, it is difficult to make low resistance ohmic contacts. To determine the effect of the contact regions, the normalized conductance change in the TFT as a function of pH for TFTs with and without heavily doped source/drain pads was explored. The observed changes are plotted in Fig. 6 . At a pH of 3, a normalized conductance change of just below 9% is obtained on TFT biosensors with heavily doped source/drain pads, compared with just below 6% for junctionless biosensors without the n+ source/drain pads. This result confirms that the contact regions are degrading the performance of the biosensor.
To better understand the effect of the source/drain contact and series resistance in TFT biosensors, device simulations were performed to determine whether the TiN contacts were ohmic. This was done by defining a metal semiconductor (Schottky) contact in the device simulator and then varying the contact work function (ϕ). The measurement and simulation results are shown in Fig. 7 , where it can be seen that the shape of the measured current-voltage characteristic is predicted using values of work function in the range 0-4.47 eV. When higher values of work function are used, strong saturation of the source/drain current is seen due to the action of the source/drain contacts. The simulated values of work function (up to 4.47 eV) for TiN ohmic contacts are consistent with reported values in the literature between 4.30 and 4.65 eV [20] . As the measured current-voltage characteristics of the low-doped TFT biosensor do not show strong saturation, it can be concluded that the TiN contacts in this device are ohmic. Thus, the TiN contacts are ohmic even in the lowdoped biosensor, which has a doping concentration of around 4 × 10 17 cm −3 .
Further simulations were carried out to investigate the role of GBs on the TFT biosensor behavior. Fig. 8 shows simulated current/voltage characteristics of a low-doped TFT biosensor for different numbers of GBs. A measured current/voltage characteristic is shown along with the simulation results for different numbers of GBs, with a simulation result for crystalline silicon as a benchmark. As expected, the biosensor current decreases as the number of GBs increases because the effective mobility is reduced. This result indicates that TFT biosensors would be expected to operate at lower currents than comparable single-crystal silicon biosensors made in SOI silicon. However, if operation at a particular current level is required, this can be achieved by adjusting the width of the TFT biosensor to give the required current. It can be seen that good agreement between measured and simulated characteristics is obtained for a device with 72 GBs.
To investigate the effect of doping on the TFT biosensor behavior, current/voltage characteristics for different doping concentrations were simulated and compared with the measured current-voltage characteristics for a low-doped TFT biosensor (Fig. 9) . As expected, the biosensor current decreases as the doping concentration is reduced. Furthermore, the shape of the current-voltage curve becomes less linear as the doping concentration is reduced. This finding is consistent with the measured results in Fig. 4 , which show a linear relationship between current and voltage for the high-doped TFT biosensor but a nonlinear relationship for the low-doped biosensor. Good agreement between measured and simulated characteristics is obtained for a doping concentration of 1.0 × 10 17 cm −3 . This is in reasonable agreement with the doping concentration of around 4 × 10 17 cm −3 extracted from Fig. 3 , given that the mobility model in the simulator has not been adjusted to fit the measured value of Hall mobility.
To investigate the effect of heavily doped source/drain contact and series resistance in the low-doped TFT biosensor, simulations were performed in which the TiN ohmic contact was modeled as a source/drain series resistor, R ser , with a fixed value. This resistor models the total resistance between the edge of the SU8 sensor window and the TiN tracks, and hence includes contact resistance and the series resistance of the source/drain end regions of the TFT biosensor. Fig. 10 shows simulated current/voltage characteristics for different values of R ser and for comparison measured characteristics for the low-doped TFT biosensor. As expected, the biosensor current decreases as R ser increases. Good agreement between measured and simulated characteristics is obtained for a value of R ser around 1.2 M . From the experimental results in Fig. 4(a) , the total resistance of the low-doped TFT biosensor varies from 3.3 M at low drain bias to 7.0 M at high drain bias. Since the pH measurements were taken at low drain bias, the source/drain series resistance of 1.2 M can be compared with a total TFT biosensor resistance of 3.3 M , which represents about 36% of the total resistance. The pH sensing results in Fig. 6 show that low-doped junctionless TFT biosensors without n+ source/drain pads show a conductance change of 5.4%, compared with 8.6% with heavily doped source/drain pads, a 37% reduction. This reduction in conductance change is in excellent agreement with the simulated 36% that the contact end regions contribute to the total biosensor resistance. The reduction in conduction change during pH sensing in the low-doped biosensors can therefore be explained by the series resistance of the source/drain contact regions.
When designing a TFT biosensor, the doping concentration should be reasonably low to achieve a high sensitivity. Simulations of nanowire biosensors in [18] indicated that a doping concentration in the range 1 × 10 17 − 1 × 10 18 cm −3 is a suitable choice, but at this low doping concentration series resistance of the source/drain contacts will be an issue. The channel length of the biosensor should therefore be designed to give a source/drain series resistance that is a small fraction of the total biosensor resistance. For the contact technology and doping concentration used in our low-doped TFT biosensor, a channel length of 400 μm would give a device in which the series resistance of the source/drain region contributes only 5% to the total biosensor resistance. Interestingly, the simulations in [18] predict a small increase in sensitivity with decreasing channel length. However, this benefit of channel length scaling will only be obtained if the source/drain series resistance is also scaled.
To demonstrate the operation of the low-doped TFT as a biosensor, low-doped TFT biosensors were functionalized with anti-CRP antibody to create a biosensor for CRP sensing. Fig. 11 (red curve) shows the percentage electric signal change (conductance change G/G 0 %) versus CRP concentration. The percentage conduction change is indicated in the graph as a percentage coverage change (coverage %) so that the Fig. 11 . Titration curve obtained using the low-doped TFT biosensor for the reaction of CRP in 0.1 mM buffer (red curve). Detection of CRP using an ELISA in 0.1 mM phosphate buffer at pH7 is also shown for comparison (blue curve).
affinity titration curve can be compared with the standard enzyme linked immunosorbent assay (ELISA) for CRP (blue curve). In this case, the percentage coverage corresponds to the optical absorbance signal change of the ELISA. The standard ELISA was performed with the same concentrations of CRP suspended in the same phosphate buffer pH7 used for the electrical sensing. The agreement between the biosensor and ELISA results is reasonably good, indicating that the change in conductance seen in the TFT biosensor is consistent with protein binding.
The above results have shown that a simple three-mask topdown TFT process can be used to create a biosensor. This approach has the advantage over bottom-up self-assembled nanowire biosensors that the location and dimensions of the biosensor are accurately defined using photolithography. It also has the advantage over CMOS-based nanowire biosensors that there is no requirement for advanced lithography and expensive SOI wafers. However, source/drain contact and series resistance in low-doped TFT biosensors degrades the sensitivity during sensing. This problem can be solved by adding heavily doped source/drain pads, but at the cost of an additional mask. As discussed above, a better approach is to design the TFT biosensor in the three-mask process so that the source/drain series resistance is only a small fraction of the total resistance. This can be done by adjusting the channel length of the biosensor. It may also be possible to reduce the contact resistance by either introducing a low-resistance barrier layer or by siliciding the contacts.
IV. CONCLUSION
In conclusion, we have presented a simple three-mask technology for the fabrication of polysilicon TFT biosensors for application in Point of Care diagnostics. The polysilicon was in situ doped to avoid the requirement for ion implantation, and the three masks were polysilicon definition, metallization, and sensing window definition. TiN has been used for the metallization, as it is a hard material that can be used to directly attach the biosensor chip to a printed circuit board without the requirement for wire bonding. The technology is simple and suitable for the mass manufacture of disposable biosensors.
The effect of source/drain series resistance on biosensor performance has been extensively investigated using electrical measurements, device simulations, and pH sensing experiments. Electrical measurements on completed biosensors, and associated device simulations, have shown that ohmic contacts to TiN are obtained for the complete range of doping concentrations studied. To maximize the biosensor sensitivity in our three-mask TFT technology, the biosensor should be designed so that the source/drain contact and series resistance is a small fraction of the total biosensor resistance. For a doping concentration around 4 × 10 17 cm −3 , a channel length of 400 μm gives a device in which the source/drain contact and series resistance contributes only 5% to the total biosensor resistance. This channel length can be scaled provided that the source/drain contact and series resistance is similarly scaled. Nevertheless, even without extensive optimization of the biosensor design, we have demonstrated that the TFT biosensor can be successfully used to sense CRP.
